Showing results (2331-2340 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|December 26, 2025
Treatment kinetics and local response during and after bridging radiotherapy prior to CAR-T cell therapy for lymphomasDaniella Klebaner, Natalie J Park, Mallika Marar, et al.
Leukemia & Lymphoma|January 7, 2026
Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemiaGuan-Hua Hu, Ying-Xi Zuo, Xiao-Hui Zhang, et al.
Leukemia & Lymphoma|December 22, 2025
Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphomaShuhei Matsumoto, Yuya Kurihara, Yasutaka Masuda, et al.
Leukemia & Lymphoma|December 25, 2025
Hemophagocytic lymphohistiocytosis is characterized by tissue factor-driven coagulopathy, endothelial injury, and immunothrombosisTanvi Y P Verma, Ivo M B Francischetti
Leukemia & Lymphoma|December 22, 2025
Adverse outcomes and high incidence of therapy-related neoplasms in patients with the t(16;21)/RUNX1::RUNX1T3 fusionDongmei Guo, Cui Wang, Jingya Yao, et al.
Leukemia & Lymphoma|December 25, 2025
Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic optionsFriyana Bhabha, H Miles Prince, Belinda Campbell, et al.
Leukemia & Lymphoma|December 18, 2025
Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemiaAlice J Liu, Emily Batterham, Rithin Nedumannil, et al.
Leukemia & Lymphoma|December 16, 2025
NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemiaJohn R Sanchez, Chaomei Liu, Vishakha Pawar, et al.
Leukemia & Lymphoma|November 3, 2025
Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023Inna Y Gong, Bahar Rafinejad-Farahani, Haris Majeed, et al.
Leukemia & Lymphoma|November 3, 2025
The role of the bone marrow microenvironment in disease progression and drug resistance in multiple myeloma in the era of novel agentsLudovica Guadagno, Jacqueline Schütt, Kerstin Brinkert, et al.
Pageof 1,001